According to a new market report published by Lucintel, the future of the protein binding assay market looks promising with opportunities in the pharmaceutical & biotechnology industry. The global protein binding assay market is expected to grow with a CAGR of 11% from 2020 to 2025. The major drivers for this market are rising research and development activities in the pharmaceutical sector, increasing drug development activities, and growing pressure to reduce cost incurred in discovery and development of drugs.
To download report brochure, please go to https://www.lucintel.com/protein-binding-assay-market.aspx and click "download brochure" tab from the menu
Protein binding assays is a method or a procedure that helps in analyzing the interaction between two molecules, such as a protein binding another protein, a small molecule, or a nucleic acid. In this market, instrument, kits & reagents, and services are the major product and service segments. Lucintel forecasts that instruments will remain the fastest growing product and service segment over the forecast period due to rising demand for user-friendly instruments and automated systems for detection of protein binding.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing protein binding studies for drug discovery & development and the rising focus on development of biologics.
North America will remain the largest region over the forecast period due to increasing research activities related to drug discovery and presence of major pharmaceutical and biotechnology companies in the region.
Merck, Thermo Fisher Scientific, GE Healthcare, Sovicell, Absorption Systems, HTdialysis, Eurofins Scientific, ADMEcell, 3B Pharmaceuticals, Biotium, and Danaher are among the major suppliers in the global protein binding assay market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global protein binding assay market by product and service, technology, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Protein Binding Assay Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global protein binding assay market by product and service, technology, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Instrument
Kits & Reagents
Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Equilibrium Dialysis
Ultrafiltration
Ultracentrifugation
Other Technologies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical & Biotechnology Companies
Contract Research Organization
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.